Carmustine and Malignant neoplasm progression - a phase IV clinical study of FDA data
Summary:
Malignant neoplasm progression is reported as a side effect among people who take Carmustine (carmustine), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Etoposide, and have Non-hodgkin's lymphoma.
The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.
What is Carmustine?
Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.
What is Malignant neoplasm progression?
Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,511 drugs and 1,635 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.
4,562 people reported to have side effects when taking Carmustine.
Among them, 157 people (3.44%) have Malignant neoplasm progression.
Among these 157 people:
How long have people been on Carmustine when they have Malignant neoplasm progression? *
What is the gender of people who have Malignant neoplasm progression when taking Carmustine? *
What is the age of people who have Malignant neoplasm progression when taking Carmustine? *
What are other drugs people take besides Carmustine? *
What are other side effects people have besides Malignant neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Carmustine and have Malignant neoplasm progression?
- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Carmustine:
- Carmustine (4,562 reports)
Malignant neoplasm progression treatments and more:
- Malignant neoplasm progression (107,528 reports)
How severe was Malignant neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of carmustine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Carmustine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,511 drugs)
Browse all the conditions that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,635 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Esomeprazole Sodium and Naproxen - 7 seconds ago
- Could Cabometyx cause Hyperthyroidism Aggravated? - 9 seconds ago
- Type 1 Diabetes and Staphylococcal Infection - 9 seconds ago
- Mirena vs. Drospirenone And Ethinyl Estradiol, side effect and effectiveness comparison - 12 seconds ago
- Could Escitalopram Oxalate cause Renal Impairment? - 17 seconds ago
- Could Contac cause Pneumonia? - 18 seconds ago
- Could Nicoderm Cq cause Acute Kidney Failure? - 19 seconds ago
- Drug interactions of Entresto and Pacerone - 24 seconds ago
- Drug interactions of Centrum and Paxlovid - 25 seconds ago
- Could Clonidine cause Renal Cyst? - 34 seconds ago